Completed PHASE3 INTERVENTIONAL 3-arm NCT02989519

Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

Comparison of the Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

Sponsor: Sanpasitthiprasong Hospital

Conditions Preterm Delivery

Interventions Micronized progesterone dydrogesterone

Updated 7 times since 2017 Last updated: Oct 7, 2017 Started: Aug 31, 2015 Primary completion: Jan 5, 2017 Completion: Mar 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Preterm Delivery, this trial is completed. The trial is conducted by Sanpasitthiprasong Hospital and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Oct 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

May 2017 — Oct 2017 [monthly]

Completed PHASE3

Status: Recruiting → Completed
Jan 2017 — May 2017 [monthly]

Recruiting PHASE3

First recorded

Aug 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanpasitthiprasong Hospital

Data source: Sanpasitthiprasong Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nai Muang, Thailand